West Pharmaceutical Services, Inc. (BMV:WST)

BMV:WST Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	628.5	484.6	853.9	894.3	762.6	615.5
Cash & Short-Term Investments	628.5	484.6	853.9	894.3	762.6	615.5
Cash Growth	28.03%	-43.25%	-4.52%	17.27%	23.90%	40.17%
Receivables	652.5	575.8	533.5	523.7	503.6	385.3
Inventory	438	377	434.7	414.8	378.4	321.3
Other Current Assets	104.3	100.7	114.3	86.7	97.4	51.6
Total Current Assets	1,823	1,538	1,936	1,920	1,742	1,374
Property, Plant & Equipment	1,874	1,716	1,513	1,263	1,127	1,012
Long-Term Investments	220.9	202.1	210	204.9	207.7	214.7
Goodwill	110.6	106	108.5	107.3	109.9	111.1
Other Intangible Assets	8.9	10.8	15.1	18.4	23	30.5
Long-Term Accounts Receivable	-	-	-	-	-	10.9
Long-Term Deferred Tax Assets	27.9	26	25.7	65.6	48.5	16
Long-Term Deferred Charges	-	-	-	-	-	0.4
Other Long-Term Assets	40.6	44.6	21.3	38.4	55.9	25
Total Assets	4,106	3,643	3,830	3,617	3,314	2,794
Accounts Payable	255.8	239.3	242.4	215.4	232.2	213.1
Accrued Expenses	111.8	138	161.3	141.1	186.1	149.1
Current Portion of Long-Term Debt	-	-	134	2.2	44.2	2.3
Current Portion of Leases	22.9	18.8	17.7	16	9.3	10.1
Current Income Taxes Payable	33.3	31.5	16.6	29.5	26.3	26
Current Unearned Revenue	-	49.6	41.7	57.3	48.7	51
Other Current Liabilities	211.6	73.2	58.1	57.5	47.3	51.8
Total Current Liabilities	635.4	550.4	671.8	519	594.1	503.4
Long-Term Debt	202.7	202.6	72.8	206.7	208.8	258.5
Long-Term Leases	77.4	83.9	84.5	93	63	60.4
Long-Term Unearned Revenue	-	3.6	12.2	10.9	-	-
Pension & Post-Retirement Benefits	31.1	28.2	29.6	28.2	40.5	57.5
Long-Term Deferred Tax Liabilities	22.8	20.5	12.7	14.3	4.9	10.4
Other Long-Term Liabilities	84.9	71.9	64.9	59.8	67.1	49.1
Total Liabilities	1,054	961.1	948.5	931.9	978.4	939.3
Common Stock	18.8	18.8	18.8	18.8	18.8	18.8
Additional Paid-In Capital	-	22.1	120.2	232.2	249	267.3
Retained Earnings	4,262	3,957	3,523	2,988	2,457	1,847
Treasury Stock	-1,127	-1,057	-637.6	-370.9	-229.5	-167.7
Comprehensive Income & Other	-102.3	-258.1	-143.8	-183	-159.6	-110.6
Shareholders' Equity	3,052	2,682	2,881	2,685	2,335	1,855
Total Liabilities & Equity	4,106	3,643	3,830	3,617	3,314	2,794
Total Debt	303	305.3	309	317.9	325.3	331.3
Net Cash (Debt)	325.5	179.3	544.9	576.4	437.3	284.2
Net Cash Growth	77.87%	-67.09%	-5.46%	31.81%	53.87%	162.18%
Net Cash Per Share	4.47	2.43	7.24	7.60	5.73	3.75
Filing Date Shares Outstanding	71.94	72.3	73.3	74.14	74.28	74.1
Total Common Shares Outstanding	71.9	72.3	73.5	74.1	74.2	74.02
Working Capital	1,188	987.7	1,265	1,401	1,148	870.3
Book Value Per Share	42.44	37.10	39.20	36.23	31.47	25.05
Tangible Book Value	2,932	2,566	2,757	2,559	2,203	1,713
Tangible Book Value Per Share	40.78	35.48	37.52	34.54	29.68	23.14
Land	-	27.9	33.7	29	29.3	24.8
Buildings	-	916.1	771.5	663.6	644.8	618.1
Machinery	-	1,631	1,518	1,388	1,298	1,201
Construction In Progress	-	410.8	415.2	305.9	242.7	192.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.